Clinical Trials Directory

Trials / Completed

CompletedNCT01944215

Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.

Detailed description

The primary objective of this study is to determine if exercise, fasting, or eating prior to a molecular breast imaging study will have an effect on the uptake of the radiotracer Tc-99m sestamibi in the breast tissue. Tc-99m sestamibi is primarily extracted by the liver. Changes in hepatic blood flow may therefore influence the amount of radiotracer available for uptake in the breast tissue.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMealeffect of meal
OTHERExerciseeffect of exercise
RADIATIONSestamibireduce radiation dose
DRUGCaffeine Tableteffect of caffeine
OTHERExternal HeatingHeating Pad and warm blanket robe

Timeline

Start date
2013-09-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2013-09-17
Last updated
2017-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01944215. Inclusion in this directory is not an endorsement.